The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

George V. Papatheodoridis

2nd Department of Internal Medicine

Athens University Medical School

Hippokration General Hospital

Athens

Greece

[email]@med.uoa.gr

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • 2nd Department of Internal Medicine, Athens University Medical School, Hippokration General Hospital, Athens, Greece. 2006 - 2011
  • Hellenic Foundation for Gastroenterology & Nutrition, 30 P. Ioakim Street, Athens, Greece. 2007 - 2010

References

  1. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study. Papatheodoridis, G.V., Manolakopoulos, S., Touloumi, G., Vourli, G., Raptopoulou-Gigi, M., Vafiadis-Zoumbouli, I., Vasiliadis, T., Mimidis, K., Gogos, C., Ketikoglou, I., Manesis, E.K. Gut (2011) [Pubmed]
  2. Treatment of HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues. Papatheodoridis, G.V. Liver Int. (2011) [Pubmed]
  3. Serum apoptotic caspase activity in chronic hepatitis C and nonalcoholic Fatty liver disease. Papatheodoridis, G.V., Hadziyannis, E., Tsochatzis, E., Georgiou, A., Kafiri, G., Tiniakos, D.G., Margariti, K., Manolakopoulos, S., Manesis, E.K., Archimandritis, A.J. J. Clin. Gastroenterol. (2010) [Pubmed]
  4. Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review. Papatheodoridis, G.V., Lampertico, P., Manolakopoulos, S., Lok, A. J. Hepatol. (2010) [Pubmed]
  5. A Greek survey of community prevalence and characteristics of constipation. Papatheodoridis, G.V., Vlachogiannakos, J., Karaitianos, I., Karamanolis, D.G. Eur. J. Gastroenterol. Hepatol (2010) [Pubmed]
  6. Current management of hepatitis B virus infection before and after liver transplantation. Papatheodoridis, G.V., Cholongitas, E., Archimandritis, A.J., Burroughs, A.K. Liver Int. (2009) [Pubmed]
  7. Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver disease. Papatheodoridis, G.V., Chrysanthos, N., Cholongitas, E., Pavlou, E., Apergis, G., Tiniakos, D.G., Andrioti, E., Theodossiades, G., Archimandritis, A.J. J. Hepatol. (2009) [Pubmed]
  8. Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection. Papatheodoridis, G.V., Chrysanthos, N., Hadziyannis, E., Cholongitas, E., Manesis, E.K. J. Viral Hepat. (2008) [Pubmed]
  9. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection. Papatheodoridis, G.V., Hadziyannis, E., Tsochatzis, E., Chrysanthos, N., Georgiou, A., Kafiri, G., Manolakopoulos, S., Tiniakos, D.G., Giannousis, I., Manesis, E.K., Archimandritis, A.J. Gut (2008) [Pubmed]
  10. Resistance issues in treating chronic hepatitis B. Papatheodoridis, G.V., Deutsch, M. Future. Microbiol (2008) [Pubmed]
  11. Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection? Papatheodoridis, G.V., Manesis, E.K., Manolakopoulos, S., Elefsiniotis, I.S., Goulis, J., Giannousis, J., Bilalis, A., Kafiri, G., Tzourmakliotis, D., Archimandritis, A.J. Hepatology (2008) [Pubmed]
  12. Therapeutic strategies in the management of patients with chronic hepatitis B virus infection. Papatheodoridis, G.V., Manolakopoulos, S., Dusheiko, G., Archimandritis, A.J. Lancet. Infect. Dis (2008) [Pubmed]
  13. Review article: novel therapeutic options for chronic hepatitis C. Cholongitas, E., Papatheodoridis, G.V. Aliment. Pharmacol. Ther. (2008) [Pubmed]
  14. Ethics related to liver biopsies and antiviral therapies in chronic viral hepatitis. Papatheodoridis, G.V. Dig. Dis (2008) [Pubmed]
  15. High prevalence of elevated liver enzymes in blood donors: associations with male gender and central adiposity. Papatheodoridis, G.V., Goulis, J., Christodoulou, D., Manolakopoulos, S., Raptopoulou, M., Andrioti, E., Alexandropoulos, N., Savvidou, S., Papachristou, A., Zervou, E., Seferiadis, K., Kousidou, P., Vogiatzakis, E., Tsianos, E. Eur. J. Gastroenterol. Hepatol (2007) [Pubmed]
  16. Effects of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on peptic ulcer disease: a systematic review. Papatheodoridis, G.V., Sougioultzis, S., Archimandritis, A.J. Clin. Gastroenterol. Hepatol. (2006) [Pubmed]
  17. Drug evaluation: LB-80380--a novel phosphonate nucleoside for the potential treatment of HBV infection. Papatheodoridis, G.V., Manolakopoulos, S. Curr. Opin. Mol. Ther. (2006) [Pubmed]
 
WikiGenes - Universities